» Articles » PMID: 33088927

Pomegranate Derivative Urolithin A Enhances Vitamin D Receptor Signaling to Amplify Serotonin-related Gene Induction by 1,25-dihydroxyvitamin D

Overview
Specialty Biochemistry
Date 2020 Oct 22
PMID 33088927
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Mediated by the nuclear vitamin D receptor (VDR), the hormonally active vitamin D metabolite, 1,25-dihydroxyvitamin D (1,25D), is known to regulate expression of genes impacting calcium and phosphorus metabolism, the immune system, and behavior. Urolithin A, a nutrient metabolite derived from pomegranate, possibly acting through AMP kinase (AMPK) signaling, supports respiratory muscle health in rodents and longevity in by inducing oxidative damage-reversing genes and mitophagy. We show herein that urolithin A enhances transcriptional actions of 1,25D driven by co-transfected vitamin D responsive elements (VDREs), and dissection of this genomic effect in cell culture reveals: 1) urolithin A concentration-dependency, 2) occurrence with isolated natural VDREs, 3) nuclear receptor selectivity for VDR over ER, LXR and RXR, and 4) significant 3- to 13-fold urolithin A-augmentation of 1,25D-dependent mRNA encoding the widely expressed 1,25D-detoxification enzyme, CYP24A1, a benchmark vitamin D target gene. Relevant to potential behavioral effects of vitamin D, urolithin A elicits enhancement of 1,25D-dependent mRNA encoding tryptophan hydroxylase-2 (TPH2), the serotonergic neuron-expressed initial enzyme in tryptophan metabolism to serotonin. Employing quantitative real time-PCR, we demonstrate that mRNA is induced 1.9-fold by 10 nM 1,25D treatment in culture of differentiated rat serotonergic raphe (RN46A-B14) cells, an effect magnified 2.5-fold via supplementation with 10 μM urolithin A. This potentiation of 1,25D-induced mRNA by urolithin A is followed by a 3.1- to 3.7-fold increase in serotonin concentration in culture medium from the pertinent neuronal cell line, RN46A-B14. These results are consistent with the concept that two natural nutrient metabolites, urolithin A from pomegranate and 1,25D from sunlight/vitamin D, likely acting via AMPK and VDR, respectively, cooperate mechanistically to effect VDRE-mediated regulation of gene expression in neuroendocrine cells. Finally, gedunin, a neuroprotective natural product from Indian neem tree that impacts the brain derived neurotropic factor pathway, similarly potentiates 1,25D/VDR-action.

Citing Articles

Preventing Recurrent Otitis Media in Children Aged 2-7 Years: A Cross-Sectional Evaluation of Serum Vitamin D as a Modifiable Factor.

Manole A, Marcut L, Carciumaru R, Manole F Diagnostics (Basel). 2025; 15(5).

PMID: 40075767 PMC: 11898411. DOI: 10.3390/diagnostics15050519.


A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan.

Chamoli M, Rane A, Foulger A, Chinta S, Shahmirzadi A, Kumsta C Nat Aging. 2023; 3(12):1529-1543.

PMID: 37957360 PMC: 10797806. DOI: 10.1038/s43587-023-00524-9.


Urolithins: A Prospective Alternative against Brain Aging.

An L, Lu Q, Wang K, Wang Y Nutrients. 2023; 15(18).

PMID: 37764668 PMC: 10534540. DOI: 10.3390/nu15183884.

References
1.
Ryu D, Mouchiroud L, Andreux P, Katsyuba E, Moullan N, Nicolet-Dit-Felix A . Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. 2016; 22(8):879-88. DOI: 10.1038/nm.4132. View

2.
Bakhshalizadeh S, Amidi F, Shirazi R, Shabani Nashtaei M . Vitamin D3 regulates steroidogenesis in granulosa cells through AMP-activated protein kinase (AMPK) activation in a mouse model of polycystic ovary syndrome. Cell Biochem Funct. 2018; 36(4):183-193. DOI: 10.1002/cbf.3330. View

3.
Jiang P, Zhang L, Cai H, Li H, Liu Y, Tang M . Neurochemical effects of chronic administration of calcitriol in rats. Nutrients. 2014; 6(12):6048-59. PMC: 4277014. DOI: 10.3390/nu6126048. View

4.
Seshadri S, Beiser A, Selhub J, Jacques P, Rosenberg I, DAgostino R . Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346(7):476-83. DOI: 10.1056/NEJMoa011613. View

5.
Ishimoto H, Shibata M, Myojin Y, Ito H, Sugimoto Y, Tai A . In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. Bioorg Med Chem Lett. 2011; 21(19):5901-4. DOI: 10.1016/j.bmcl.2011.07.086. View